eMedicine Specialties > Radiology > Brain/Spine

Pineal Germinoma

Author: Chi-Shing Zee, MD, Chief of Neuroradiology, Professor, Departments of Radiology and Neurosurgery, University of Southern California School of Medicine
Coauthor(s): Paul Kim, MD, Assistant Professor of Radiology, USC School of Medicine; Vi Vu, MD, Clinical Instructor, USC School of Medicine
Contributor Information and Disclosures

Updated: Apr 18, 2007

Introduction

Background

Although pineal region neoplasms constitute only 0.3-2.7% of intracranial tumors, they are considered an important clinical entity because of their strategic location. Pineal region neoplasms can be classified into 3 major groups according to their cellular origin: (1) tumors of germ cell origin, (2) tumors of pineal cell origin, and (3) tumors of other cell origin. Tumors of germ cell origin include germinoma, mature teratoma, malignant teratoma, embryonal cell carcinoma, endodermal sinus tumor, choriocarcinoma, and mixed germ cell tumors. In addition, pineal germinomas and suprasellar germinomas are associated. Pineal germinomas are seen predominantly in males aged 0-20 years.

Pathophysiology

Herophilus discovered the pineal gland in 300 BC, and Galen labeled the gland konareion, meaning shaped like a pinecone.

From a physiologic perspective, the pineal gland is centrally situated to serve as the center of a system of input, feedback, and regulation among diverse areas in the brain. Human physiologic systems evolve cyclically, with an internal awareness of diurnal and seasonal cycles. The pineal gland is responsible for both clock and calendar information. Through the production and release of numerous neurohormonal substances, the pineal gland integrates the signals it receives from the environment. Of the various substances produced by the pineal gland, melatonin is the most important. The control of melatonin synthesis by light makes the photoperiodicity of the pineal gland possible.

Many types of neoplasms can arise from the pineal region owing to the presence of various histologically unrelated tissues. Neoplasms include those of the pineal gland (eg, germ cell tumors, pineal cell tumors); thalamic quadrigeminal plate and tectum (eg, glioma); ependyma (eg, ependymoma); and velum interpositum and tentorium (eg, meningioma). Metastasis and vascular lesions have also been reported.

The most common pineal tumors are germinomas. Germinomas are most commonly seen in the pineal region, followed by the suprasellar region. Occasionally, they may be seen in the thalamus or basal ganglia. The cellular origin of germinoma usually is ascribed to primitive germ cells that are believed to migrate over wide areas of the embryo during early fetal life. Other germ cell tumors include embryonal cell carcinoma, endodermal sinus carcinoma, choriocarcinoma, and mixed germ cell tumor; however, these are much less common than germinomas.

The marker profile in cerebrospinal fluid or serum may be helpful in the differential diagnosis of germ cell tumors in the pineal region. Choriocarcinoma produces human chorionic gonadotropin, endodermal sinus tumor produces alpha fetoprotein, and embryonal cell carcinoma produces alpha fetoprotein and human chorionic gonadotropin. Mixed germ cell tumors may produce a combination of these tumor markers.

Frequency

United States

Pineal region neoplasms constitute 0.3-2.7% of all intracranial tumors. Germinoma is the most common pineal region neoplasm, constituting approximately 40% of cases. Pineal germinomas occur more frequently in males and are more common than suprasellar germinomas.

International

A high incidence of pineal germinoma is found in Japan.

Mortality/Morbidity

  • Overall 5-year survival rate for patients with a pineal region or suprasellar germinoma treated with radiation is 59%.
  • The 5-year survival rate for patients aged 25 years or younger who do not undergo biopsy for a tumor in the pineal region is 81% after radiation treatment. Most of these tumors are probably germinomas.

Race

The incidence of pineal region neoplasms is high in Japanese individuals.

Sex

  • Pineal germinomas are seen predominantly in males, with a 9:1 male-to-female ratio.
  • Suprasellar germinomas affect males and females equally.

Age

Germinomas appear in persons aged 0-20 years.

Anatomy

The pineal gland is situated deep in the brain near critical neural and vascular structures. This position accounts for the neurologic symptoms that may occur when a mass lesion arises in the pineal gland. The pineal gland is located in the most posterior portion of the roof of the third ventricle. The posterior commissure is posterior and inferior to the pineal gland. Anterior to the pineal gland are the habenular trigone and the striae medullaris thalami. The splenium of the corpus callosum is situated above the pineal gland.

The pineal gland is located in the pineal recess of the third ventricle and surrounded by a pial layer. The substances produced by the pineal gland are released into the vascular system. Through numerous perforators, the medial posterior choroidal arteries are the major feeders of the gland. A large venous outflow proceeds through the internal cerebral veins and the vein of Galen and contributes to the distribution of substances synthesized in the pineal gland.

Presentation

Parinaud syndrome, a condition secondary to compression of the tectum, is the most important clinical presentation of pineal germinomas. The triad of Parinaud syndrome includes palsy of the upward gaze, dissociation of light and accommodation, and failure of convergence. In addition, findings secondary to hydrocephalus resulting from aqueductal compression are seen. Pineal germinomas may be associated with precocious puberty in male patients.

Preferred Examination

MRI is the preferred imaging modality. MRI enables the accurate delineation of pineal masses before surgery. MRI allows true pineal masses to be distinguished from parapineal masses that impinge on the pineal gland.

Limitations of Techniques

MRI is not perfect in the detection of calcifications. CT may be needed to evaluate a calcified pineal gland that is associated with a pineal germinoma or tumor calcification associated with other neoplasms in the pineal region.

Differential Diagnoses

Astrocytoma, Brain
Ganglioglioma
Meningioma, Brain

Other Problems to Be Considered

Other pineal germ cell tumors
Pineocytoma
Pineoblastoma
Metastasis

More on Pineal Germinoma

Overview: Pineal Germinoma
Imaging: Pineal Germinoma
Multimedia: Pineal Germinoma
References

References

  1. Allen JC, Nisselbaum J, Epstein F, et al. Alphafetoprotein and human chorionic gonadotropin determination in cerebrospinal fluid. An aid to the diagnosis and management of intracranial germ-cell tumors. J Neurosurg. Sep 1979;51(3):368-74. [Medline].

  2. Chang CG, Kageyama N, Kobayashi T, et al. Pineal Tumors: clinical diagnosis, with special emphasis on the significance of pineal calcification. Neurosurgery. Jun 1981;8(6):656-68. [Medline].

  3. Edwards MS, Hudgins RJ, Wilson CB, et al. Pineal region tumors in children. J Neurosurg. May 1988;68(5):689-97. [Medline].

  4. Farng KT, Chang KP, Wong TT. Pediatric intracranial germinoma treated with chemotherapy alone. Chung Hua I Hsueh Tsa Chih (Taipei). Dec 1999;62(12):859-66. [Medline].

  5. Ganti SR, Hilal SK, Stein BM, et al. CT of pineal region tumors. AJR Am J Roentgenol. Mar 1986;146(3):451-8. [Medline].

  6. Hoffman HJ, Otsubo H, Hendrick EB, et al. Intracranial germ-cell tumors in children. J Neurosurg. Apr 1991;74(4):545-51. [Medline].

  7. Jenkin D, Berry M, Chan H, et al. Pineal region germinomas in childhood treatment considerations. Int J Radiat Oncol Biol Phys. Mar 1990;18(3):541-5. [Medline].

  8. Jenkin RD, Simpson WJ, Keen CW. Pineal and suprasellar germinomas. Results of radiation treatment. J Neurosurg. Jan 1978;48(1):99-107. [Medline].

  9. Kilgore DP, Strother CM, Starshak RJ, Haughton VM. Pineal germinoma: MR imaging. Radiology. Feb 1986;158(2):435-8. [Medline].

  10. Kluczewska E, Staniek-Sadowska J, Malecka-Tendera E. [Radiological evaluation of pineal pathology and its regions]. Neurol Neurochir Pol. Sep-Oct 1999;33(5):1129-38. [Medline].

  11. Koide O, Watanabe Y, Sato K. Pathological survey of intracranial germinoma and pinealoma in Japan. Cancer. Apr 15 1980;45(8):2119-30. [Medline].

  12. Lin SR, Crane MD, Lin ZS, et al. Characteristics of calcification in tumors of the pineal gland. Radiology. Mar 1978;126(3):721-6. [Medline].

  13. Moon WK, Chang KH, Han MH, Kim IO. Intracranial germinomas: correlation of imaging findings with tumor response to radiation therapy. AJR Am J Roentgenol. Mar 1999;172(3):713-6. [Medline].

  14. Rivarola, Belgorosky A, Mendilaharzu H. Precocious puberty in children with tumours of the suprasellar and pineal areas: organic central precocious puberty. Acta Paediatr. Jul 2001;90(7):751-6. [Medline].

  15. Smirniotopoulos JG, Rushing EJ, Mena H. Pineal region masses: differential diagnosis. Radiographics. May 1992;12(3):577-96. [Medline].

  16. Tamaki N, Yin D. Therapeutic strategies and surgical results for pineal region tumours. J Clin Neurosci. Mar 2000;7(2):125-8. [Medline].

  17. Teo HE, Tan AM. Clinics in diagnostic imaging (37). Germinoma of the pineal gland. Singapore Med J. May 1999;40(5):375-8. [Medline].

  18. Zee CS, Segall H, Apuzzo M, et al. MR imaging of pineal region neoplasms. J Comput Assist Tomogr. Jan-Feb 1991;15(1):56-63. [Medline].

  19. Zimmerman RA, Bilaniuk LT, Wood JH, et al. Computed tomography of pineal, parapineal, and histologically related tumors. Radiology. Dec 1980;137(3):669-77. [Medline].

  20. Zimmerman RA, Bilaniuk LT. Age-related incidence of pineal calcification detected by computed tomography. Radiology. Mar 1982;142(3):659-62. [Medline].

Further Reading

Keywords

pineal gland, pineal region neoplasms, germ cell tumors, pineal cell tumors, germinoma, mature teratoma, malignant teratoma, embryonal cell carcinoma, endodermal sinus tumor, choriocarcinoma, mixed germ cell tumor, parapineal masses, thalamic quadrigeminal plate and tectum, glioma, ependyma, ependymoma, velum interpositum and tentorium, meningioma, Parinaud syndrome

Contributor Information and Disclosures

Author

Chi-Shing Zee, MD, Chief of Neuroradiology, Professor, Departments of Radiology and Neurosurgery, University of Southern California School of Medicine
Chi-Shing Zee, MD is a member of the following medical societies: American Society of Neuroradiology
Disclosure: Nothing to disclose.

Coauthor(s)

Paul Kim, MD, Assistant Professor of Radiology, USC School of Medicine
Disclosure: Nothing to disclose.

Vi Vu, MD, Clinical Instructor, USC School of Medicine
Disclosure: Nothing to disclose.

Medical Editor

Pamela W Schaefer, MD, Assistant Professor of Radiology, Harvard Medical School; Associate Director of Neuroradiology, Clinical Director of Magnetic Resonance Imaging, Department of Radiology, Massachusetts General Hospital
Disclosure: Nothing to disclose.

Pharmacy Editor

Bernard D Coombs, MB, ChB, PhD, Consulting Staff, Department of Specialist Rehabilitation Services, Hutt Valley District Health Board, New Zealand
Disclosure: Nothing to disclose.

CME Editor

Robert M Krasny, MD, Consulting Staff, Department of Radiology, The Angeles Clinic and Research Institute
Robert M Krasny, MD is a member of the following medical societies: American Roentgen Ray Society and Radiological Society of North America
Disclosure: Nothing to disclose.

Chief Editor

James G Smirniotopoulos, MD, Professor of Radiology, Neurology, and Biomedical Informatics, Chairman, Department of Radiology and Radiological Sciences, Uniformed Services University of the Health Sciences
James G Smirniotopoulos, MD is a member of the following medical societies: American College of Radiology, American Roentgen Ray Society, American Society of Head and Neck Radiology, American Society of Neuroradiology, American Society of Pediatric Neuroradiology, Association of University Radiologists, and Radiological Society of North America
Disclosure: Nothing to disclose.

 
 
HONcode

We subscribe to the
HONcode principles of the
Health On the Net Foundation

All material on this website is protected by copyright, Copyright© 1994- by Medscape.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.